Company research / BMRN

BIOMARIN PHARMACEUTICAL INC (BMRN)

CIK 0001048477 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, BIOMARIN PHARMACEUTICAL INC reported revenue of $3.22B. Revenue grew 12.9% from the prior annual period.

Key ratios (year ended 2025-12-31)

12.7%
Operating margin
10.8%
Net margin
5.7%
Return on year-end equity
12.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-03

Headquarters locality: Novato · View on map

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.